Amino terminal cleavage of PTH(1-84) to PTH(7-84) is regulated by serum calcium concentration via calcium-sensing receptor in hemodialysis patients

Clinical and Experimental Nephrology

Volumn 14, Issue 3, 2010, Pages 233-238

  Koshikawa, Masao ^a   Nishiguchi, Kensuke ^a   Yorifuji, Soshi ^a   Shimazu, Keiji ^a   Takaori, Koji ^a   Mori, Keita ^a   Eguchi, Eriko ^a   Okada, Kikuo ^a   Tanaka, Atsuo ^a   Kuwahara, Takashi ^a  

^a SAISEIKAI NAKATSU HOSPITAL   (Japan)

Author keywords

Calcimimetics; Calcium sensing receptor; Carboxyl terminal (C ) fragment; Parathyroid hormone (PTH); Secondary hyperparathyroidism; Vitamin D

Indexed keywords

22 OXACALCITRIOL; ALFACALCIDOL; CALCIMIMETIC AGENT; CALCITRIOL; CALCIUM; CALCIUM ION; CALCIUM SENSING RECEPTOR; CINACALCET; PARATHYROID HORMONE; PARATHYROID HORMONE[7-84]; UNCLASSIFIED DRUG; VITAMIN D; NAPHTHALENE DERIVATIVE; PARATHYROID HORMONE (7 84); PARATHYROID HORMONE (7-84); PEPTIDE FRAGMENT;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM BLOOD LEVEL; CORRELATION ANALYSIS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; SECONDARY HYPERPARATHYROIDISM; BLOOD; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

CALCIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; RECEPTORS, CALCIUM-SENSING; RENAL DIALYSIS; VITAMIN D;

EID: 77956644216     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0264-5     Document Type: Article

References (23)

1. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem. 1998;44: 805-809
2. Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt- Gayk H, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res. 2001;16:605-614
3. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, et al. A novel mechanism for skeletal resistance in uremia. Kidney Int. 2000;58:753-761
4. Usatii M, Rousseau L, Demers C, Petit JL, Brossard JH, Gascon- Barré M, et al. Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1, 25(OH)2D synthesis. Kidney Int. 2007;72:1330-1335
5. Kawata T, Imanishi Y, Kobayashi K, Onoda N, Takemoto Y, Tahara H, et al. Direct in vitro evidence of extracellular Ca2?- induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells. J Clin Endocrinol Metab. 2005;90:5774-5778
6. Mayer GP, Keaton JA, Hurst JG, Habener JF. Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood. Endocrinology. 1979;104:1778-1784
7. Tamura T, Sakamoto H, Filburn CR. Parathyroid hormone 1-34, but not 3-34 or 7-34, transiently translocates protein kinase C in cultured renal (OK) cells. Biochem Biophys Res Commun. 1989;159:1352-1358
8. Fujimori A, Cheng SL, Avioli LV, Civitelli R. Structure-function relationship of parathyroid hormone: activation of phospholipase- C, protein kinase-A and -C in osteosarcoma cells. Endocrinology. 1992;130:29-36.
9. Sneddon WB, Syme CA, Bisello A, Magyar CE, Rochdi MD, Parent JL, et al. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J Biol Chem. 2003;278:43787-43796
10. Divieti P, Inomata N, Chapin K, Singh R, Jüppner H, Bringhurst FR. Receptors for the carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells. Endocrinology. 2001;142:916-925
11. Nguyen-Yamamoto L, Rousseau L, Brossard JH, Lepage R, D'Amour P. Synthetic carboxyl-terminal fragments of parathyroidhormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor. Endocrinology. 2001;142:1386-1392
12. Wada M, Furuya Y, Sakiyama J, Kobayashi N, Miyata S, Ishii H, et al. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor. J Clin Invest. 1997;100:2977-2983
13. Colloton M, Shatzen E, Miller G, Stehman-Breen C, Wada M, Lacey D, et al. Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism Kidney Int. 2005 67: 467-476
14. Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab. 2003;88:5644-5649
15. Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, et al. The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol. 2002;13: 1017-1024
16. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004; 350:1516-1525
17. Martin KJ, Jüppner H, Sherrard DJ, Goodman WG, Kaplan MR, Nassar G, et al. First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int. 2005;68:1236-1243
18. Demay MB, Kiernan MS, DeLuca HF, Kronenberg HM. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA. 1992;89:8097-8101
19. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest. 1984;74:2136-2143
20. Tsukamoto Y, Hanaoka M, Matsuo T, Saruta T, Nomura M, Takahashi Y. Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism. Am J Kidney Dis. 2000;35:458-464
21. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest. 1986;78:1296-1301
22. Kazama JJ, Omori K, Higuchi N, Takahashi N, Ito Y, Maruyama H, et al. Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant. 2004;19:892-897
23. Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem. 2002;277:30337-30350